- ... States.[ 1 - 3 ] Neoadjuvant chemotherapy as given in ... the designation, neoadjuvant, to distinguish it from standard adjuvant therapy, ...
- ... describe recommended basic standards for the collection of clinical trial data. ... (highly recommended, recommended/conditional, or optional). Version 1. ...
- ... the European Medicines Agency (EMA) granted TRIAC orphan designation for the treatment of AHDS (EMA/695502/2017). To follow this first clinical study, an international Phase II trial (NCT02396459) to investigate the effects of TRIAC on ...
- ... AHOD1331 (NCT02166463) high-risk Hodgkin lymphoma initial therapeutics ... for a complete response designation if the PET is negative. The results of ...
- ... be considered interventional in European countries. Because the designation of a ... trial submission and compliance with clinical trial regulations), it ...
- ... for clinical use has recently achieved Orphan Drug designation by European Medicines ... clinical trials using complement inhibitors that block the activation of ...
- ... Hidvegi et al 2010 ]. Carbamazepine received orphan drug designation by the European Commission for the treatment of SMCD in September 2016 (EMA/OD/148/16 and EMA/COMP/513538/2016). Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on ...
- ... blinded trials have a stronger study design. A designation “s” is given to acupuncture ... controlled clinical trials: Studies in which participants are assigned to a ...
- ... meaningfully different from a simple race or ethnicity designation, and these ... trials or studies. Clinical variables. With regard to disease ...
- ... occurred only in patients with diffuse anaplasia. Current Clinical Trials Use our advanced clinical trial search to find ... of these differences achieved statistical significance.[ 174 ] Current Clinical Trials Use our advanced clinical trial search to find ...
234 results